Cargando…
Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation
BACKGROUND: Special AT-rich sequence-binding protein 1 (SATB1) is a chromatin-remodeling protein that regulates gene expressions in different types of cancer. Up-regulation of SATB1 is linked with progression of tumors. Our previous study showed that SATB1 expression was decreased in T cell leukemia...
Autores principales: | Luo, Xiaodan, Xu, Lihua, Wu, Xiaohong, Tan, Huo, Liu, Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525380/ https://www.ncbi.nlm.nih.gov/pubmed/31130823 http://dx.doi.org/10.1186/s12935-019-0850-x |
Ejemplares similares
-
The mRNA expression of SATB1 and SATB2 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2009) -
Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML
por: Shi, Li, et al.
Publicado: (2013) -
Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells
por: Huang, Bo, et al.
Publicado: (2013) -
RNA helicase DHX15 decreases cell apoptosis by NF-κB signaling pathway in Burkitt lymphoma
por: Chen, Yuan, et al.
Publicado: (2022) -
MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation
por: Du, Xinyue, et al.
Publicado: (2020)